-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Achilles Therapeutics plc quarterly/annual General and Administrative Expense history and change rate from 2019 to Q2 2024.
- Achilles Therapeutics plc General and Administrative Expense for the quarter ending 30 Jun 2024 was $4.16M, a 3.57% decline year-over-year.
- Achilles Therapeutics plc annual General and Administrative Expense for 2023 was $17M, a 19.5% decline from 2022.
- Achilles Therapeutics plc annual General and Administrative Expense for 2022 was $21.1M, a 3.87% decline from 2021.
- Achilles Therapeutics plc annual General and Administrative Expense for 2021 was $22M, a 98% increase from 2020.
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Change (%)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Change (%)